Nanoscope Kickstarts BLA Submission for Restorative RP Therapy, Adds to Advisory Board
BLA filed, big brains recruited—Nanoscope is charging ahead with its promising gene-agnostic therapy for retinitis pigmentosa. Nanoscope Therapeutics (Texas, USA)…
Viridian Shares New 52-Week Phase III Trial Data for Active TED
New THRIVE trial data highlight long-term proptosis response with veligrotug in thyroid eye disease patients. Fresh long-term data is showing…
popular posts
